(Received for publication, July 6, 1995; and in revised form, August 25, 1995)
From the
Furin is a Golgi membrane-associated endoprotease that is involved in cleavage of various precursor proteins predominantly at Arg-X-Lys/Arg-Arg sites. Furin itself is synthesized as an inactive precursor, which is activated through intramolecular autocatalytic cleavage at an Arg-X-Lys-Arg site. We previously found that human colon carcinoma LoVo cells have a frameshift mutation within the homo B domain of furin and thereby lack processing activity toward Arg-X-Lys/Arg-Arg sites. In this study, however, we identified a second furin mutation in this cell line. The mutation, a replacement of a conserved Trp residue within the homo B domain with Arg, results in lack of processing activity of the mutant furin. The combination of both mutations can account for the recessive nature of the processing incompetence of LoVo cells. Immunofluorescence analysis with three distinct anti-furin monoclonal antibodies revealed that neither furin mutant underwent the autocatalytic activation or left the endoplasmic reticulum for the Golgi. These data indicate that the homo B domain as well as the catalytic domain is required for autocatalytic activation of furin.
A variety of biologically active peptides and proteins are
synthesized as inactive precursors, which undergo endoproteolytic
cleavage at sites marked by paired or multiple basic amino acids to
yield mature products. A novel family of mammalian endoproteases
homologous to the yeast Kex2 protease has been shown recently to play a
key role in the proprotein processing. These include furin, PC1/3, PC2,
PC4, PACE4, and PC5/6 (for review, see Seidah et al.(1991),
Steiner et al.(1992), and Halban and Irminger(1994)). Furin is
a membrane-associated protease that is predominantly localized to the trans-Golgi network (Misumi et al., 1991; Molloy et al., 1994). It is expressed ubiquitously and catalyzes
cleavage of a wide variety of precursor proteins, such as those for
growth factors, serum proteases, receptors, and viral envelope
glycoproteins, at sites marked mainly by Arg-X-Lys/Arg-Arg
(RXK/RR) consensus sequence (Bresnahan et al., 1990;
Hatsuzawa et al., 1992; Hosaka et al., 1991; Misumi et al., 1991; Molloy et al., 1994). Furin itself is
synthesized as an inactive zymogen and is activated by intramolecular
autocatalytic removal of its propeptide through cleavage at the
RXKR site (Leduc et al., 1992; Creemers et
al., 1993). Most recent studies have revealed that the
autocatalytic propeptide removal occurs in the endoplasmic reticulum
(ER) ()and is a prerequisite for transport of furin out of
this compartment to the trans-Golgi network (Molloy et
al., 1994; Vey et al., 1994; Creemers et al.,
1995). This is also the case with the yeast Kex2 protease (Gluschankof
and Fuller, 1994).
Direct evidence for involvement of furin in precursor cleavage at RXK/RR sites has been provided by studies on processing-incompetent cell lines. A human colon carcinoma cell line, LoVo, has been shown to be incapable of cleaving endogenous proreceptors for insulin and hepatocyte growth factor at the RXK/RR sites (Mondino et al., 1991; Komada et al., 1993). We (Takahashi et al., 1993) have recently shown that the processing incompetence is ascribed to a one-nucleotide deletion in the furin gene that shifts the open reading frame and causes an aberrant termination of the furin polypeptide in the homo B domain (also known as M or P domain). The homo B domain as well as the subtilisin-like catalytic domain has been shown to be essential for the endoproteolytic activity of furin and the yeast Kex2 protease (Hatsuzawa et al., 1992; Creemers et al., 1993; Gluschankof and Fuller, 1994). The furin mutation in LoVo cells appears to be recessive, since transfection of furin compensated for the processing deficiency (Komada et al., 1993; Takahashi et al., 1993). On the other hand, Moehring and co-workers (Moehring and Moehring, 1983; Watson et al., 1991) established a mutant CHO-K1 cell line, named RPE.40, which is resistant to Pseudomonas exotoxin and various enveloped viruses. They have recently indicated that the resistance is ascribed to the lack of endoproteolytic cleavage of the toxin and viral envelope glycoproteins, which are normally cleaved by furin, although the molecular identity of the mutation in RPE.40 cells is unknown (Moehring et al., 1993; Inocencio et al., 1994).
Since our identification of the furin mutation in LoVo cells, many researchers have made use of this cell line for studies on precursor processing and demonstrated that furin is involved in processing of a wide variety of precursor proteins (for example, Tsuneoka et al.(1993), Ohnishi et al.(1994), Inocencio et al.(1994), Paquet et al.(1994), Hiromoto et al.(1994)). However, we have recently found by reverse transcriptase-polymerase chain reaction (RT-PCR) analysis that LoVo cells possess not only one type of furin cDNA having the one-nucleotide deletion in the homo B domain but also another type with a sequence that appears to be normal around this mutation site. This is incompatible with the notion that the furin mutation in LoVo cells is recessive. We therefore started to address this problem.
Figure 1: Schematic representation of the structure of furin cDNA. The coding region is boxed. Relative positions of oligonucleotide primers used for RT-PCR are shown by arrows. Predicted epitope regions of antifurin monoclonal antibodies are shown by solid bars. SP, signal peptide; Cys-rich, Cys-rich domain; TMD, transmembrane domain.
In the earlier study, we showed that the lack of precursor-processing activity toward RXK/RR sites of human colon carcinoma LoVo cells is ascribed to a mutation in furin (Takahashi et al., 1993). The mutation is a one-nucleotide deletion; while four consecutive T residues are present from nucleotide residues 1,283 to 1,286 (the numbering is according to Van den Ouweland et al.(1990)) in wild type human furin cDNA, three consecutive ones are in the LoVo furin cDNA (see Fig. 1). This deletion shifts the open reading frame with an altered amino acid sequence beginning with the codon for amino acid 429 within the homo B domain, which, in addition to the subtilisin-like catalytic domain, is thought to be essential for furin activity (Hatsuzawa et al., 1992; Creemers et al., 1993). We hereafter refer to this mutant furin as 429FS (for frame shift from amino acid 429). However, by RT-PCR analysis of LoVo cell RNA, we recently noticed the presence of another type of cDNA, which had four consecutive T residues. If the furin molecule encoded by the second cDNA has endoproteolytic activity, the finding would be incompatible with the recessive nature of LoVo cells with respect to the processing deficiency. We therefore pursued analysis of additional furin cDNAs from LoVo cells.
We first amplified a cDNA region from LoVo cell RNA by RT-PCR using a set of primers; one corresponding to a part of 5`-untranslated region (primer 1) and the other complementary to a region downstream of the 4T/3T site (primer 3) (see Fig. 1). The amplified fragment was subcloned into a vector and subjected to partial sequence analysis. Of six independent clones analyzed, five clones had four T residues as in wild type cDNA, while one had three T residues as in 429FS cDNA. We therefore constructed a chimeric furin cDNA vector with a substitution of a fragment from the 5`-terminus to the unique XhoI site (see Fig. 1) of each clone having four T residues for the corresponding fragment of wild type cDNA. To determine if the chimeric furin has endoproteolytic activity, LoVo cells were co-transfected with the chimeric construct and a vector for prorenin with an RXKR cleavage site. Although the data are not shown, all the chimeras examined showed endoproteolytic activity toward the RXKR substrate. This data indicated that, at least within the region from 5`-terminus to the XhoI site, the LoVo cDNA of 4T type does not have any mutation that affects the furin activity.
We then amplified the other cDNA region from LoVo cell RNA using primer 2 corresponding to a region upstream of the 4T/3T site and primer 4 complementary to a part of 3`-untranslated region (see Fig. 1). Of 10 independent clones subjected to partial sequence analysis, seven clones were 4T type, while three clones were 3T type. Since the partial sequence analysis revealed that the 4T clones did not have any mutation from the 5`-terminus of the cloned cDNA fragment to the unique XhoI site, we prepared chimeric constructs as shown schematically in Fig. 2A; a region of each LoVo furin cDNA from the XhoI site to the 3`-terminus was substituted for the corresponding one of wild type cDNA. The construct was then transfected into LoVo cells in combination with the RXKR prorenin vector to determine if the chimeras had endoproteolytic activity. As shown in Fig. 2B, LoVo cells transfected with a chimeric construct of wild type furin cDNA and a LoVo cell cDNA clone 10 of 3T type, cleaved the prorenin substrate like those transfected with the wild type furin vector. This indicates that, as shown in our previous study (Takahashi et al., 1993), the 429FS-type cDNA has no mutation that affects the furin activity within the substituted region; that is, from the XhoI site to the 3`-terminus. By contrast, transfection of either chimera of wild type furin and each 4T-type LoVo furin cDNA (clone 1, 4, or 7) did not give rise to cleavage of the substrate at the RXKR site. These observations indicated that the region from the XhoI site to the 3`-terminus derived from each LoVo cell cDNA clone, which appeared to be normal at the 4T/3T site, had some mutation that affects the furin activity.
Figure 2: Processing activity of chimeric furin. A, schematic representation of the structure of the chimera of wild type (WT) and LoVo furin cDNAs. A WT cDNA fragment from the 5`-terminus to a unique XhoI site was ligated with a fragment from the XhoI site to the 3`-terminus derived from each LoVo cell cDNA clone. Details are described under ``Experimental Procedures.'' B, transfection assay of chimeric furin. LoVo cells were transfected with a control vector(-) or a vector carrying WT or chimeric furin in combination with an RXKR prorenin vector. Produced renin molecules were analyzed as described under ``Experimental Procedures.'' The positions of prorenin and renin are indicated. 3T or 4T in parentheses indicates that the LoVo cell cDNA portion of the chimeric construct was derived from a 3T- or 4T-type clone.
Sequence analysis revealed that there was one nucleotide substitution within a region covering the homo B domain; the T residue at nucleotide 1,639 was replaced by C (Fig. 3A). This nucleotide substitution causes replacement of a codon for Trp (TGG) at amino acid 547 by that for Arg (CGG); therefore, we hereafter call this type of mutation as W547R. All the sequenced clones, which appeared to be normal with respect to the 4T/3T site, had the mutation of T to C, whereas all the 3T type clones did not have the W547R substitution. We confirmed that there is not any mutation in the cloned region other than the mutation of T to C by sequencing of three 4T clones. Furthermore, the mutation was also found in genomic DNA of LoVo cells; 4T-type genomic DNA had the T to C mutation, while 3T-type DNA did not have the mutation (data not shown). Taken together with our previous data for 429FS-type mutation (Takahashi et al., 1993), we conclude that the presence of two mutant alleles of furin, one for 429FS and the other for W547R, results in the processing incompetence of LoVo cells, being compatible with the recessive nature of the incompetence.
Figure 3: Structure of LoVo cell furins. A, autoradiograph of the sequencing gel of wild type (WT) human furin cDNA and a new mutant cDNA of LoVo cells (W547R). B, comparison of the amino acid sequence of the pertinent region of human furin with those of other Kex2 family members. Residues conserved across all members are shown in dark boxes. The position of the Trp residue mutated in W547R furin is indicated by an asterisk. The sequence data were taken from: human (h) furin, Van den Ouweland et al., 1990; mouse (m) PC1/3, Nakayama et al., 1991; hPC2, Smeekens and Steiner, 1990; mPC4, Nakayama et al., 1992; mPACE4, Hosaka et al., 1994; mPC5/6, Nakagawa et al., 1993; Xenopus furin (XEN-14), Korner et al., 1991; Drosophila (D) furin1, Roebroek et al., 1991; Dfurin2, Roebroek et al., 1992; Caenorhabditis elegans (ce) PC2, Gómez-Saladín et al., 1994; Lymnaea (l) PC2, Smit et al., 1992; Hydra (hy) PC3-like, Chan et al., 1992; Aplysia (a) PC1A and PC1B, Chun et al., 1994; Saccharomyces cerevisiae (sc) Kex2, Mizuno et al., 1988; Schizosaccharomyces pombe (sp) Krp, Davey et al., 1994. C, schematic representation of the structures of WT furin and mutant furins of LoVo cells (429FS and W547R). SP, signal peptide; TMD, transmembrane domain.
As shown schematically in Fig. 3C, the W547R mutation is positioned in the
COOH-terminal part of the homo B domain. Comparison with other Kex2
family members revealed that the Trp residue within the homo B domain
is completely conserved in this family (Fig. 3B).
Around the region including the Trp residue, there is a consensus
motif,
WXWXEX
GXW (X for any amino acid); the last W is the residue mutated in
furin of LoVo cells. It is noteworthy that, in this motif, three Trp
residues are spaced at intervals of eight residues, although the
significance is unknown since data base analysis failed to show the
existence of other proteins having this motif outside the Kex2 family.
Our previous studies have shown that the homo B domain as well as the subtilisin-like catalytic domain is essential for furin activity (Hatsuzawa et al., 1992; Creemers et al., 1993). With respect to the catalytic domain, it is known that a mutation at either the active site Asp, His, or Ser residue blocks intramolecular autocatalytic cleavage of the furin propeptide, whereas an oxyanion hole mutant and a negative side chain mutant do undergo the autocatalytic maturation but lack substrate processing activity (Creemers et al., 1993, 1995). Furthermore, the autoproteolytic removal of the propeptide has been shown to be prerequisite for transport of furin out of the ER to the Golgi (Molloy et al., 1994; Vey et al., 1994; Creemers et al., 1995). However, it remained to be determined whether the homo B domain is required for substrate processing activity or autocatalytic activation. To address this issue, we expressed wild type furin and 429FS and W547R mutants in COS-7 cells and stained these cells with three distinct monoclonal antibodies to furin, which recognize distinct epitopes of furin polypeptide (Van Duijnhoven et al., 1992). As shown schematically in Fig. 1A, epitopes of these antibodies are within the following regions: MON-148, the catalytic domain; MON-150, the propeptide region; MON-152, a region COOH-terminal to the homo B domain. When stained with the antibody to the catalytic domain, MON-148 (Fig. 4), COS-7 cells expressing wild type furin gave a perinuclear staining characteristic of the Golgi. By contrast, the cells expressing 429FS or W547R gave a reticular staining throughout the cytoplasm but not a Golgi-like one. The reticular staining was well correlated with that produced by an antibody to BiP, a well characterized marker protein for the ER, indicating that neither mutant exited the ER. The data also indicate that the region downstream of amino acid 429 is not required for retention of the furin precursor in the ER. MON-152 produced a Golgi-like and an ER-like staining patterns for wild type and W547R furin, respectively, as those observed with MON-148, but did not produce any significant staining for 429FS (Fig. 5). This is in agreement with the fact that 429FS lacks the region containing the epitope of MON-152 due to the frameshift mutation. When stained with the propeptide antibody, MON-150 (Fig. 6), cells expressing wild type furin did not produce any significant staining. This observation together with those shown in Fig. 4and Fig. 5indicate that all the wild type furin molecules have left the ER for the Golgi after autocatalytic removal of the propeptide. By contrast, an ER-like staining but not a Golgi-like one was observed with MON-150 in cells expressing 429FS or W547R like that with MON-148. These observations together with those in Fig. 4and Fig. 5indicate that neither mutant is able to go out of the ER due to the lack of autoproteolytic removal of the propeptide.
Figure 4: Intracellular localization of wild type and mutant furin detected with MON-148. COS-7 cells transiently transfected with a construct for wild type (WT), 429FS, or W547R furin were fixed and double-stained with a monoclonal antibody to furin MON-148, which recognizes an epitope within the catalytic domain (see Fig. 1) and anti-BiP antibody as described under ``Experimental Procedures.''
Figure 5: Intracellular localization of wild type and mutant furin detected with MON-152. COS-7 cells transiently transfected with a construct for wild type (WT), 429FS, or W547R furin were fixed and double-stained with a monoclonal antibody to furin MON-152, which recognizes an epitope within a region COOH-terminal to the homo B domain (see Fig. 1) and anti-BiP antibody as described under ``Experimental Procedures.''
Figure 6: Intracellular localization of wild type and mutant furin detected with MON-150. COS-7 cells transiently transfected with a construct for wild type (WT), 429FS, or W547R furin were fixed and double-stained with a monoclonal antibody to furin MON-150, which recognizes an epitope within the propeptide region (see Fig. 1), and anti-BiP antibody as described under ``Experimental Procedures.''
As described so far, the present study establishes the following. First, LoVo cells lack processing activity toward RXK/RR sites due to the presence of two distinct mutant alleles of furin, 429FS and W547R. The combination of the two alleles can account for the recessive nature of the processing incompetence of LoVo cells. The detailed characterization will make this processing-deficient cell line a more useful tool for processing studies.
Second, the homo B domain is essential for autoproteolytic activation of furin, so that neither mutant can leave the ER. Surprisingly, the mutation of only one amino acid (Trp at amino acid 547) within this domain completely blocks the autocatalytic activation. To date, researchers have distinguished, for convenience sake, between the subtilisin-like catalytic and homo B domains, since the former but not the latter one is present in the prototypical proteases, bacterial subtilisins. However, our previous (Hatsuzawa et al., 1992; Creemers et al., 1993) and present studies using furin and the study of Gluschankof and Fuller(1994) using the yeast Kex2 protease have shown that the homo B domain is also essential for the autocatalytic activation process. Kex2-like proteases have more strict substrate specificity than subtilisins, making it tempting to speculate that an additional region is required for keeping the strict specificity. Although the three-dimensional structure of furin has been modeled on the basis of x-ray crystallographic data of subtilisin BPN` and thermitase, this model is restricted to the subtilisin-like domain (Van de Ven et al., 1990; Siezen et al., 1994). To understand the overall structure and thereby the molecular mechanisms that underlie the autocatalytic activation and substrate cleaving processes of Kex2 family proteases, it must therefore await x-ray crystallographic analysis of the proteases themselves.
Finally, the region downstream of amino acid 429, including a most portion of the homo B domain, and the Cys-rich, transmembrane, and cytoplasmic domains, is not implicated in the ER retention of profurin. Especially, this indicates that association of the furin molecule with membranes is not implicated in the precursor retention. Although the molecular mechanism that underlies the ER retention of profurin is currently unknown, the presence of an ER-resident protein that interacts with the pro- but not mature form of furin could account for the ER retention (Creemers et al., 1995). It is tempting to speculate that such a retention protein might be a molecular chaperone essential for correct folding of profurin. Identification of an ER protein(s) that interacts with the furin precursor will be required to understand the mechanism of the ER retention.